Workflow
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
SONNSonnet BioTherapuetics(SONN) Newsfilter·2024-06-20 20:30

In consideration for the immediate exercise of the Existing Warrants for cash, Sonnet will issue new unregistered warrants to purchase up to 5,657,000 shares of common stock (the "New Warrants"). The New Warrants will have an exercise price of $1.55 per share (priced at-the-market under the rules of the Nasdaq Stock Market), will be exercisable upon issuance, and have a term equal to five years from the date of issuance. In connection with the transaction, Sonnet also (i) reduced the exercise price of the E ...